The Food and Drug Administration is expected to approve the latest Covid boosters as early as Monday, Christina Jewett of The New York Times reports. The Centers for Disease Control and Prevention is expected to hold an advisory meeting to discuss who should get the new shots, which are by Pfizer(PFE)-BioNTech (BNTX) and Moderna (MRNA). This vaccine campaign will be the first since the end of the public health emergency, which expired in May.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PFE:
- Pfizer Stock (NYSE:PFE) Hits a New Low; What’s Ahead?
- FDA plans to ok updated versions of Covid booster as soon as Friday, NBC says
- Novartis sues U.S. government over price regulation, Reuters reports
- MHRA approves Pfizer/BioNTech’s Omicron XBB.1.5 adapted COVID-19 vaccine
- H.C. Wainwright bullish on GeoVax Labs given ‘notable’ 1H23 achievements
